Focus on mitochondria dysfunction and dysregulation in heart failure: Towards new therapeutic strategies to improve heart function

Congestive Heart Failure

Volumn 17, Issue 6, 2011, Pages 255-256

  Kurdi, Mazen ^a   Booz, George W ^b  

^a LEBANESE UNIVERSITY   (Lebanon)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

APOPTOSIS; EDITORIAL; FATTY ACID OXIDATION; HEART FAILURE; HEART FUNCTION; HEART MITOCHONDRION; HUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; ENERGY METABOLISM; HEART FAILURE; HUMANS; MITOCHONDRIA, HEART; OXIDATIVE STRESS; PRACTICE GUIDELINES AS TOPIC;

EID: 81955161802     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2011.00269.x     Document Type: Editorial

References (14)

1. Kuzmicic J, Del Campo A, López-Crisosto C, et al. Mitochondrial dynamics: a potential new therapeutic target for heart failure. Rev Esp Cardiol. 2011;64:916-923.
2. Jaswal JS, Keung W, Wang W, et al. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta. 2011;1813:1333-1350.
3. Rosca MG, Hoppel CL. Mitochondria in heart failure. Cardiovasc Res. 2010;88:40-50.
4. Ventura-Clapier R, Garnier A, Veksler V, Joubert F. Bioenergetics of the failing heart. Biochim Biophys Acta. 2011;1813:1360-1372.
5. Chen L, Knowlton AA. Mitochondrial dynamics in heart failure. Congest Heart Fail. 2011 doi: 10.1111/j.1751-7133.2011.00255.x.
6. Parra V, Verdejo H, del Campo A, et al. The complex interplay between mitochondrial dynamics and cardiac metabolism. J Bioenerg Biomembr. 2011;43:47-51.
7. Iglewski M, Hill JA, Lavandero S, Rothermel BA. Mitochondrial fission and autophagy in the normal and diseased heart. Curr Hypertens Rep. 2010;12:418-425.
8. Hollander JM, Baseler WA, Dabkowski ER. Proteomic remodeling of mitochondria in heart failure. Congest Heart Fail. 2011 doi: 10.1111/j.1751-7133.2011.00254.x.
9. Rosca MG, Vazquez EJ, Kerner J, et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res. 2008;80:30-39.
10. O'Rourke B, Van Eyk J, Foster DB. Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunctrion in heart failure. Congest Heart Fail. 2011 doi: 10.1111/j.1751-7133.2011.00266.x.
11. Rosca M, Minkler P, Hoppel CL. Cardiac mitochondria in heart failure: normal cardiolipin profile and increased threonine phosphorylation of complex IV. Biochim Biophys Acta. 2011;1807:1373-1382.
12. Nediani C, Raimondi L, Borchi E, Cerbai E. Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid Redox Signal. 2011;14:289-331.
13. Zweier JL, Chen CA, Talukder MA. Cardiac resynchronization therapy and reverse molecular remodeling: importance of mitochondrial redox signaling. Circ Res. 2011;109:716-719.
14. Wang SB, Foster DB, Rucker J, et al. Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ Res. 2011;109:750-757.